Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Papeix

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
JAMA Neurology|September 5, 2023
Vaccines and the Risk of Hospitalization for Multiple Sclerosis Flare-UpsLamiae Grimaldi, Caroline Papeix, Yann Hamon, et al.
Neurology|October 11, 2015
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodiesRabab Debs, Elisabeth Maillart, Robert Fahed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2018
False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotinValérie Pourcher, Eve Todesco, Claire Dubois, et al.
Brain : a Journal of Neurology|September 13, 2022
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegenerationMatteo Tonietto, Emilie Poirion, Andrea Lazzarotto, et al.
Neurology|February 26, 2017
Fast multiple sclerosis progression in North Africans: Both genetics and environment matterYoussef Sidhom, Elisabeth Maillart, Sophie Tezenas du Montcel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?Marine Boudot de la Motte, Céline Louapre, Anne Bertrand, et al.
Journal of Neurology|April 23, 2022
Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccinationLina Jeantin, Adèle Hesters, Dorine Fournier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating eventOlivier Gout, Annie Bouchareine, Antoine Moulignier, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
Prognosis of patients with multiple sclerosis associated with uveitisMarine Martin, Jean-Sébastien Vidal, Caroline Papeix, et al.
Frontiers in Neurology|February 6, 2024
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational studyRomain Marignier, David Laplaud, Hélène Zéphir, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
JAMA Neurology|September 5, 2023
Vaccines and the Risk of Hospitalization for Multiple Sclerosis Flare-UpsLamiae Grimaldi, Caroline Papeix, Yann Hamon, et al.
Neurology|October 11, 2015
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodiesRabab Debs, Elisabeth Maillart, Robert Fahed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2018
False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotinValérie Pourcher, Eve Todesco, Claire Dubois, et al.
Brain : a Journal of Neurology|September 13, 2022
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegenerationMatteo Tonietto, Emilie Poirion, Andrea Lazzarotto, et al.
Neurology|February 26, 2017
Fast multiple sclerosis progression in North Africans: Both genetics and environment matterYoussef Sidhom, Elisabeth Maillart, Sophie Tezenas du Montcel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?Marine Boudot de la Motte, Céline Louapre, Anne Bertrand, et al.
Journal of Neurology|April 23, 2022
Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccinationLina Jeantin, Adèle Hesters, Dorine Fournier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating eventOlivier Gout, Annie Bouchareine, Antoine Moulignier, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
Prognosis of patients with multiple sclerosis associated with uveitisMarine Martin, Jean-Sébastien Vidal, Caroline Papeix, et al.
Frontiers in Neurology|February 6, 2024
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational studyRomain Marignier, David Laplaud, Hélène Zéphir, et al.
Pageof 16